Dextromethorphan in Cough Syrup: The Poor Man's Psychosis.
Bridgette Martinak, Ramy A Bolis, J. Black, Rachel E. Fargason, Badari Birur
Psychopharmacology bulletin August 12, 2025 DOI: 10.64719/pb.4553 via Semantic Scholar
Summary
AI-generated from the abstractDextromethorphan (DXM), a common over-the-counter cough suppressant, can cause psychosis when abused at high doses (over 1500 mg/day), producing delusions, hallucinations, and paranoia similar to phencyclidine (PCP). A case of severe DXM use disorder with psychotic disorder in a 40-year-old woman resolved only after treatment with an antipsychotic and mood stabilizer. DXM is not detected on standard urine drug screens, and its abuse may be an under-recognized cause of substance-induced psychosis. Clinicians should be aware of these psychiatric risks.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 40-year-old Caucasian female with severe dextromethorphan use disorder and dextromethorphan-induced psychotic disorder |
| Intervention | antipsychotic and mood stabilizer |
| Keywords | Medicine |
| Key finding | A patient's dextromethorphan-induced psychotic disorder remitted only after treatment with a combination of an antipsychotic and mood stabilizer. |
Abstract
Dextromethorphan (3-methoxy-N-methylmorphinan), also known as "DXM" and "the poor man's PCP," is a synthetically produced drug that is available in more than 140 over-the-counter cough and cold preparations. Dextromethorphan (DXM) has overtaken codeine as the most widely used cough suppressant due to its availability, efficacy, and safety profile at directed doses. However, DXM is subject to abuse. When consumed at inappropriately high doses (over 1500 mg/day), DXM can induce a state of psychosis characterized by Phencyclidine (PCP)-like psychological symptoms, including delusions, hallucinations, and paranoia. We report a noteworthy case of severe dextromethorphan use disorder with dextromethorphan-induced psychotic disorder in a 40-year-old Caucasian female, whose symptoms remitted only following treatment with a combination of an antipsychotic and mood stabilizer. While some states have begun to limit the quantity of DXM sold or restrict sales to individuals over 18-years of age, there is currently no federal ban or restriction on DXM. Abuse of DXM, a readily available and typically inexpensive agent that is not detected on a standard urine drug screen, may be an under-recognized cause of substance-induced psychosis. It is imperative that clinicians are aware of the potential psychiatric sequelae of recreational DXM use.